{"title": "La OMS recomienda que se extienda el uso de la vacuna contra la malaria en \u00c1frica", "author": null, "url": null, "hostname": null, "description": "La OMS recomienda que se extienda el uso de la vacuna contra la malaria en \u00c1frica", "sitename": null, "date": "2021-10-07", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "\u201cEs un momento hist\u00f3rico. La tan esperada vacuna contra la malaria en ni\u00f1os es un gran avance para la ciencia, la salud infantil y el control de la enfermedad\u201d, afirm\u00f3 este mi\u00e9rcoles Tedros Adhanom Ghebreyesus, director general de la Organizaci\u00f3n Mundial de la Salud (\n[OMS](https://www.who.int/es)).\nPara la instituci\u00f3n, la \u00fanica vacuna aprobada contra el paludismo deber\u00eda administrarse ampliamente a los ni\u00f1os africanos, lo que podr\u00eda suponer un gran avance contra una patolog\u00eda que mata a cientos de miles de personas cada a\u00f1o.\nLa recomendaci\u00f3n es para la RTS,S, una vacuna desarrollada por GlaxoSmithKline, que debe administrarse en una pauta de cuatro dosis a partir de los cinco meses de edad\nLa recomendaci\u00f3n es para la RTS,S \u2013conocida como Mosquirix\u2013, una vacuna desarrollada por la farmac\u00e9utica brit\u00e1nica GlaxoSmithKline (\n[GSK.L](https://es.gsk.com/es-es/home/)). Debe administrarse en una pauta de cuatro dosis a partir de los cinco meses de edad para la reducci\u00f3n de la enfermedad y su carga.\nDesde 2019, se han administrado 2,3 millones de dosis de Mosquirix a beb\u00e9s de Ghana, Kenia y Malaui en un programa piloto a gran escala coordinado por la OMS, llevado a cabo tras una d\u00e9cada de ensayos cl\u00ednicos en siete pa\u00edses africanos.\n\u201cEs la mejor inversi\u00f3n posible que se ha hecho en salud p\u00fablica\u201d, apunt\u00f3 Pedro Alonso, director del Programa Global contra la Malaria de la OMS. Los resultados indican que la vacuna es segura, aunque su eficacia es relativamente baja, por lo cual debe ser usada en combinaci\u00f3n con las medidas de prevenci\u00f3n y diagn\u00f3stico ya existentes.\n\u201cSu uso, adem\u00e1s de herramientas para su prevenci\u00f3n, podr\u00eda salvar decenas de miles de vidas j\u00f3venes cada a\u00f1o\u201d, insisti\u00f3 Adhanom Ghebreyesus. \u201cEst\u00e1 desarrollada en \u00c1frica por cient\u00edficos africanos y estamos muy orgullosos\u201d. Asimismo, tiene la particularidad de ser la primera que se desarrolla contra un par\u00e1sito en humanos.\nLos resultados indican que la vacuna es segura, aunque su eficacia es relativamente baja, por lo cual debe ser usada en combinaci\u00f3n con las medidas de prevenci\u00f3n y diagn\u00f3stico ya existentes\n\u201cLlevamos mucho tiempo esperando una vacuna eficaz contra el paludismo y, por primera vez, tenemos una indicada para su uso generalizado. La recomendaci\u00f3n actual ofrece un rayo de esperanza para el continente que soporta la mayor carga de la enfermedad\u201d, puntualiz\u00f3 Matshidiso Moeti, director regional de la OMS para \u00c1frica. \u201cEsperamos que muchos m\u00e1s ni\u00f1os africanos est\u00e9n protegidos contra la malaria y se conviertan en adultos sanos\u201d.\nSi bien la eficacia de la vacuna para prevenir los casos graves de paludismo en los ni\u00f1os es solo de un 30 %, por el momento es la \u00fanica vacuna autorizada. La Agencia Europea del Medicamento (\n[EMA](https://www.ema.europa.eu/en)) la aprob\u00f3 en 2015, diciendo que sus beneficios superaban los riesgos.\nLa aprobaci\u00f3n del uso ampliado de esta vacuna permitir\u00e1 incorporarla al conjunto de herramientas que se usan en la lucha contra la malaria (mosquiteras impregnadas de insecticidas, f\u00e1rmacos con fines profil\u00e1cticos, diagn\u00f3sticos y tratamientos), pero no reemplazar\u00e1 a ninguna de ellas, explicaron los expertos. De hecho, la superposici\u00f3n de las herramientas har\u00e1 que m\u00e1s del 90 % de los ni\u00f1os se beneficien de al menos una intervenci\u00f3n preventiva.\nDe las 410.000 muertes anuales que ocurren por malaria, 260.000 corresponden a ni\u00f1os menores de cinco a\u00f1os\n\u201cHemos hecho progresos incre\u00edbles en las \u00faltimas dos d\u00e9cadas, los casos de malaria han ca\u00eddo a la mitad, pero a nivel global los casos se mantienen a un nivel demasiado alto, con 200 millones de casos anuales y m\u00e1s de 400.000 muertes\u201d, explic\u00f3 Adhanom Ghebreyesus al anunciar la recomendaci\u00f3n de la vacuna.\nSeg\u00fan la OMS, el 94 % de los casos y muertes por paludismo se producen en \u00c1frica, un continente con 1.300 millones de habitantes. Esta enfermedad prevenible est\u00e1 causada por par\u00e1sitos que se transmiten a las personas por la picadura de mosquitos infectados. Los s\u00edntomas son fiebre, v\u00f3mitos y fatiga.\nDe las 410.000 muertes anuales que ocurren por malaria, 260.000 corresponden a ni\u00f1os menores de cinco a\u00f1os. Puede contraerse varias veces en la vida y los estudios indican que cuando esto ocurre desde edades tempranas, el desarrollo y la vida futura de los ni\u00f1os pueden verse gravemente comprometidos, lo que podr\u00eda evitarse con la vacuna recomendada.\nLa vacuna aprobada ha sido administrada en los programas regulares de vacunaci\u00f3n y ha tenido un alto nivel de aceptaci\u00f3n y confianza por parte de las familias en los tres pa\u00edses donde se ha utilizado, lo que explica que entre el 80 y 90 % de ni\u00f1os peque\u00f1os la hayan recibido, seg\u00fan los datos aportados por la OMS.\nAs\u00ed, el proyecto piloto ha confirmado la viabilidad de administrar las cuatro dosis que requiere esta vacuna, su rol en la reducci\u00f3n de muertes infantiles, y que puede ser integrada a los programas nacionales de inmunizaci\u00f3n sin mayores complicaciones.\nAdem\u00e1s, se ha comprobado que la disponibilidad de una vacuna no ha llevado a que las familias que viven en zonas end\u00e9micas descuiden el uso de mosquiteras y tampoco ha tenido un impacto negativo en la cobertura de otras vacunas destinadas a ni\u00f1os.\nEsta decisi\u00f3n abre la puerta para un uso generalizado de esta vacuna, lo que salvar\u00e1 vidas y servir\u00e1 para prevenir la enfermedad entre los ni\u00f1os africanos. La que tenemos es una vacuna de primera generaci\u00f3n, pero no deber\u00eda ser la \u00faltima\nPedro Alonso (OMS)\nEso s\u00ed, la extensi\u00f3n del uso de la vacuna RTS,S requerir\u00e1 de nuevas inversiones. Pero la aprobaci\u00f3n que ha dado la OMS permitir\u00e1 que la Alianza para el Acceso a las Vacunas (conocida como\n[GAVI](https://www.gavi.org/)) considere invertir en este producto para dar acceso a los pa\u00edses m\u00e1s empobrecidos.\nEsta decisi\u00f3n \u201cabre la puerta para un uso generalizado de esta vacuna, lo que salvar\u00e1 vidas, servir\u00e1 para prevenir la enfermedad entre los ni\u00f1os africanos y esperamos que tambi\u00e9n estimule a que se retomen las investigaciones para el desarrollo de otras vacunas contra la malaria. La que tenemos es una vacuna de primera generaci\u00f3n, pero no deber\u00eda ser la \u00faltima\u201d, concluy\u00f3 el cient\u00edfico espa\u00f1ol Pedro Alonso.", "language": null, "image": null, "pagetype": null, "links": ["http://biotech-spain.com/en/", null, "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/directory", "http://biotech-spain.com/en/admin/", "http://biotech-spain.com/en/contact", "/en", "/es", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles/la-oms-recomienda-que-se-extienda-el-uso-de-la-vacuna-contra-la-malaria-en-frica/", "https://www.who.int/es", "https://es.gsk.com/es-es/home/", "https://www.ema.europa.eu/en", "https://www.gavi.org/", "http://biotech-spain.com/en/directory/agencia+sinc/", "http://biotech-spain.com/en/articles/tags/paludismo", "http://biotech-spain.com/en/articles/tags/malaria", "http://biotech-spain.com/en/articles/tags/vacuna", "http://biotech-spain.com/en/articles/tags/%c3%81frica", "http://biotech-spain.com/en/articles/tags/oms+", "https://www.agenciasinc.es/Noticias/La-OMS-recomienda-que-se-extienda-el-uso-de-la-vacuna-contra-la-malaria-en-Africa", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/articles/el-diagn-stico-gen-tico-neonatal-mejora-la-esperanza-de-vida-de-ni-os-con-una-inmunodeficiencia-letal/", "http://biotech-spain.com/en/articles/m-s-de-1-500-cambios-epigen-ticos-en-el-esperma-asociados-a-la-edad-paterna/", "http://biotech-spain.com/en/articles/tuneable-reverse-photochromes-in-the-solid-state-/", "#tab-1", "#tab-2", "http://biotech-spain.com/en/articles/eosin-filos-qu-significa-tener-valores-altos-o-bajos-/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/los-pacientes-con-psoriasis-grave-tienen-mayor-riesgo-cardiovascular/", "http://biotech-spain.com/en/articles/las-pruebas-moleculares-permiten-detectar-de-forma-m-s-eficaz-el-c-ncer-de-endometrio-y-evitar-histerectom-as-innecesarias-en-mujeres-con-sangrado-post-menop-usico/", "http://biotech-spain.com/en/articles/a-study-by-ibs-granada-reveals-that-exposure-to-perfluorinated-compounds-pfas-affects-the-reproductive-health-of-adolescents/", "http://biotech-spain.com/en/articles/key-protein-identified-in-fat-function-and-obesity-related-problems/", "http://biotech-spain.com/en/articles/incliva-y-uv-investigan-la-p-rdida-de-conectividad-entre-el-hipocampo-izquierdo-y-derecho-en-la-enfermedad-de-alzheimer/", "http://biotech-spain.com/en/articles/vhio-led-retrospective-study-evaluates-the-clinical-and-genomic-features-of-early-onset-pancreatic-cancer-/", "http://biotech-spain.com/en/articles/a-portable-sensor-could-detect-cancerous-tumors/", "http://biotech-spain.com/en/articles/tags/cancer", "http://biotech-spain.com/en/articles/tags/covid-19", "http://biotech-spain.com/en/articles/tags/alzheimer", "http://biotech-spain.com/en/articles/tags/investigaci%c3%b3n", "http://biotech-spain.com/en/articles/tags/salud", "http://biotech-spain.com/en/articles/tags/coronavirus", "http://biotech-spain.com/en/articles/tags/covid19", "http://biotech-spain.com/en/terms", "http://biotech-spain.com/en/privacy", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/articles?category=substance-abuse", "http://biotech-spain.com/en/articles?category=agrobiotechnology", "http://biotech-spain.com/en/articles?category=food-sub", "http://biotech-spain.com/en/articles?category=animal-food-feed", "http://biotech-spain.com/en/articles?category=functional-food", "http://biotech-spain.com/en/articles?category=analgesia-pain", "http://biotech-spain.com/en/articles?category=associations", "http://biotech-spain.com/en/articles?category=biobanks", "http://biotech-spain.com/en/articles?category=bioclusters", "http://biotech-spain.com/en/articles?category=biofuels", "http://biotech-spain.com/en/articles?category=biodrugs", "http://biotech-spain.com/en/articles?category=bioinformatics", "http://biotech-spain.com/en/articles?category=cellular-and-molecular-b", "http://biotech-spain.com/en/articles?category=systems-biology", "http://biotech-spain.com/en/articles?category=evolutionary-biology", "http://biotech-spain.com/en/articles?category=synthetic-biology", "http://biotech-spain.com/en/articles?category=biomarkers", "http://biotech-spain.com/en/articles?category=biomaterials", "http://biotech-spain.com/en/articles?category=marine-based-biotechnology", "http://biotech-spain.com/en/articles?category=business-angels", "http://biotech-spain.com/en/articles?category=cancer", "http://biotech-spain.com/en/articles?category=stem-cells", "http://biotech-spain.com/en/articles?category=cardiovascular-and-cir", "http://biotech-spain.com/en/articles?category=research-centers", "http://biotech-spain.com/en/articles?category=private-clinic", "http://biotech-spain.com/en/articles?category=communication-media", "http://biotech-spain.com/en/articles?category=consultancy", "http://biotech-spain.com/en/articles?category=biologic-control-plagues-", "http://biotech-spain.com/en/articles?category=quality-control", "http://biotech-spain.com/en/articles?category=corporate-investor", "http://biotech-spain.com/en/articles?category=cosmetics", "http://biotech-spain.com/en/articles?category=cell-culture", "http://biotech-spain.com/en/articles?category=gm-crops", "http://biotech-spain.com/en/articles?category=biological-defense", "http://biotech-spain.com/en/articles?category=dental", "http://biotech-spain.com/en/articles?category=dermatology", "http://biotech-spain.com/en/articles?category=muskuloskeletal", "http://biotech-spain.com/en/articles?category=biotechnology-kits", "http://biotech-spain.com/en/articles?category=software-development", "http://biotech-spain.com/en/articles?category=diagnostic-imaging", "http://biotech-spain.com/en/articles?category=medical-devices", "http://biotech-spain.com/en/articles?category=drug-delivery", "http://biotech-spain.com/en/articles?category=drug-development", "http://biotech-spain.com/en/articles?category=drug-discovery", "http://biotech-spain.com/en/articles?category=pregnancy-reproduction", "http://biotech-spain.com/en/articles?category=venture-capital-manageme", "http://biotech-spain.com/en/articles?category=energy", "http://biotech-spain.com/en/articles?category=bone-diseases", "http://biotech-spain.com/en/articles?category=chronic-diseases", "http://biotech-spain.com/en/articles?category=degenerative-diseases", "http://biotech-spain.com/en/articles?category=genetic-diseases", "http://biotech-spain.com/en/articles?category=hereditary-diseases", "http://biotech-spain.com/en/articles?category=inflamatory-diseases", "http://biotech-spain.com/en/articles?category=neurologic-diseases", "http://biotech-spain.com/en/articles?category=rares-diseases", "http://biotech-spain.com/en/articles?category=clinical-trials", "http://biotech-spain.com/en/articles?category=public-entity", "http://biotech-spain.com/en/articles?category=epidemiology", "http://biotech-spain.com/en/articles?category=epigenetics", "http://biotech-spain.com/en/articles?category=medical-and-surgica", "http://biotech-spain.com/en/articles?category=patient-monito", "http://biotech-spain.com/en/articles?category=manufacture-of-biotech", "http://biotech-spain.com/en/articles?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=manufacture-o", "http://biotech-spain.com/en/articles?category=manufa", "http://biotech-spain.com/en/articles?category=pharmacy", "http://biotech-spain.com/en/articles?category=pharmacogenomics", "http://biotech-spain.com/en/articles?category=public-financing", "http://biotech-spain.com/en/articles?category=investment-funds", "http://biotech-spain.com/en/articles?category=training", "http://biotech-spain.com/en/articles?category=foundatio", "http://biotech-spain.com/en/articles?category=foundation", "http://biotech-spain.com/en/articles?category=genomics", "http://biotech-spain.com/en/articles?category=hospitals", "http://biotech-spain.com/en/articles?category=infections", "http://biotech-spain.com/en/articles?category=engineering", "http://biotech-spain.com/en/articles?category=immunology", "http://biotech-spain.com/en/articles?category=healthcare-facilities-and", "http://biotech-spain.com/en/articles?category=scientific-t", "http://biotech-spain.com/en/articles?category=inter", "http://biotech-spain.com/en/articles?category=institutional-investor", "http://biotech-spain.com/en/articles?category=private-investor", "http://biotech-spain.com/en/articles?category=leasing", "http://biotech-spain.com/en/articles?category=environmental-cleanup-testing", "http://biotech-spain.com/en/articles?category=maintenance-cell-culture", "http://biotech-spain.com/en/articles?category=sales-marketing", "http://biotech-spain.com/en/articles?category=environment", "http://biotech-spain.com/en/articles?category=metabolomics", "http://biotech-spain.com/en/articles?category=microbiology", "http://biotech-spain.com/en/articles?category=nanotechnology", "http://biotech-spain.com/en/articles?category=neuroscience", "http://biotech-spain.com/en/articles?category=nutrition", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=oftalmology", "http://biotech-spain.com/en/articles?category=cost-optimization", "http://biotech-spain.com/en/articles?category=othe", "http://biotech-spain.com/en/articles?category=peptides", "http://biotech-spain.com/en/articles?category=science-tec", "http://biotech-spain.com/en/articles?category=probiotics", "http://biotech-spain.com/en/articles?category=blood-products", "http://biotech-spain.com/en/articles?category=disposable-medical-prod", "http://biotech-spain.com/en/articles?category=industrial-property-p", "http://biotech-spain.com/en/articles?category=proteins", "http://biotech-spain.com/en/articles?category=proteomics", "http://biotech-spain.com/en/articles?category=dna-tests", "http://biotech-spain.com/en/articles?category=diagnostic-tests", "http://biotech-spain.com/en/articles?category=scientific-publications", "http://biotech-spain.com/en/articles?category=chemistry", "http://biotech-spain.com/en/articles?category=human-resources", "http://biotech-spain.com/en/articles?category=research-network", "http://biotech-spain.com/en/articles?category=r", "http://biotech-spain.com/en/articles?category=animal-health", "http://biotech-spain.com/en/articles?category=women-s-health", "http://biotech-spain.com/en/articles?category=child-health", "http://biotech-spain.com/en/articles?category=mental-health", "http://biotech-spain.com/en/articles?category=senior-health", "http://biotech-spain.com/en/articles?category=healthy", "http://biotech-spain.com/en/articles?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/articles?category=screening", "http://biotech-spain.com/en/articles?category=food-safety", "http://biotech-spain.com/en/articles?category=cro-cmo-services", "http://biotech-spain.com/en/articles?category=research-services-and-supp", "http://biotech-spain.com/en/articles?category=legal-services", "http://biotech-spain.com/en/articles?category=auditory-system", "http://biotech-spain.com/en/articles?category=digestive-system", "http://biotech-spain.com/en/articles?category=kidney-and-geni", "http://biotech-spain.com/en/articles?category=locomotive-system", "http://biotech-spain.com/en/articles?category=metabolic-sy", "http://biotech-spain.com/en/articles?category=central-nervous-system", "http://biotech-spain.com/en/articles?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/articles?category=laser-optical-systems", "http://biotech-spain.com/en/articles?category=cellular-therapy", "http://biotech-spain.com/en/articles?category=gene-therapy", "http://biotech-spain.com/en/articles?category=tissue-therapy", "http://biotech-spain.com/en/articles?category=toxicology", "http://biotech-spain.com/en/articles?category=technology-transfer", "http://biotech-spain.com/en/articles?category=transplant", "http://biotech-spain.com/en/articles?category=universities", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=venture-capital", "http://biotech-spain.com/en/articles?category=vitamins-and-nutri", "http://biotech-spain.com/en/articles?category=viral-vector", "http://biotech-spain.com/en/directory?category=substance-abuse", "http://biotech-spain.com/en/directory?category=agrobiotechnology", "http://biotech-spain.com/en/directory?category=food-sub", "http://biotech-spain.com/en/directory?category=animal-food-feed", "http://biotech-spain.com/en/directory?category=functional-food", "http://biotech-spain.com/en/directory?category=analgesia-pain", "http://biotech-spain.com/en/directory?category=associations", "http://biotech-spain.com/en/directory?category=biobanks", "http://biotech-spain.com/en/directory?category=bioclusters", "http://biotech-spain.com/en/directory?category=biofuels", "http://biotech-spain.com/en/directory?category=biodrugs", "http://biotech-spain.com/en/directory?category=bioinformatics", "http://biotech-spain.com/en/directory?category=cellular-and-molecular-b", "http://biotech-spain.com/en/directory?category=systems-biology", "http://biotech-spain.com/en/directory?category=evolutionary-biology", "http://biotech-spain.com/en/directory?category=synthetic-biology", "http://biotech-spain.com/en/directory?category=biomarkers", "http://biotech-spain.com/en/directory?category=biomaterials", "http://biotech-spain.com/en/directory?category=marine-based-biotechnology", "http://biotech-spain.com/en/directory?category=business-angels", "http://biotech-spain.com/en/directory?category=cancer", "http://biotech-spain.com/en/directory?category=stem-cells", "http://biotech-spain.com/en/directory?category=cardiovascular-and-cir", "http://biotech-spain.com/en/directory?category=research-centers", "http://biotech-spain.com/en/directory?category=private-clinic", "http://biotech-spain.com/en/directory?category=communication-media", "http://biotech-spain.com/en/directory?category=consultancy", "http://biotech-spain.com/en/directory?category=biologic-control-plagues-", "http://biotech-spain.com/en/directory?category=quality-control", "http://biotech-spain.com/en/directory?category=corporate-investor", "http://biotech-spain.com/en/directory?category=cosmetics", "http://biotech-spain.com/en/directory?category=cell-culture", "http://biotech-spain.com/en/directory?category=gm-crops", "http://biotech-spain.com/en/directory?category=biological-defense", "http://biotech-spain.com/en/directory?category=dental", "http://biotech-spain.com/en/directory?category=dermatology", "http://biotech-spain.com/en/directory?category=muskuloskeletal", "http://biotech-spain.com/en/directory?category=biotechnology-kits", "http://biotech-spain.com/en/directory?category=software-development", "http://biotech-spain.com/en/directory?category=diagnostic-imaging", "http://biotech-spain.com/en/directory?category=medical-devices", "http://biotech-spain.com/en/directory?category=drug-delivery", "http://biotech-spain.com/en/directory?category=drug-development", "http://biotech-spain.com/en/directory?category=drug-discovery", "http://biotech-spain.com/en/directory?category=pregnancy-reproduction", "http://biotech-spain.com/en/directory?category=venture-capital-manageme", "http://biotech-spain.com/en/directory?category=energy", "http://biotech-spain.com/en/directory?category=bone-diseases", "http://biotech-spain.com/en/directory?category=chronic-diseases", "http://biotech-spain.com/en/directory?category=degenerative-diseases", "http://biotech-spain.com/en/directory?category=genetic-diseases", "http://biotech-spain.com/en/directory?category=hereditary-diseases", "http://biotech-spain.com/en/directory?category=inflamatory-diseases", "http://biotech-spain.com/en/directory?category=neurologic-diseases", "http://biotech-spain.com/en/directory?category=rares-diseases", "http://biotech-spain.com/en/directory?category=clinical-trials", "http://biotech-spain.com/en/directory?category=public-entity", "http://biotech-spain.com/en/directory?category=epidemiology", "http://biotech-spain.com/en/directory?category=epigenetics", "http://biotech-spain.com/en/directory?category=medical-and-surgica", "http://biotech-spain.com/en/directory?category=patient-monito", "http://biotech-spain.com/en/directory?category=manufacture-of-biotech", "http://biotech-spain.com/en/directory?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=manufacture-o", "http://biotech-spain.com/en/directory?category=manufa", "http://biotech-spain.com/en/directory?category=pharmacy", "http://biotech-spain.com/en/directory?category=pharmacogenomics", "http://biotech-spain.com/en/directory?category=public-financing", "http://biotech-spain.com/en/directory?category=investment-funds", "http://biotech-spain.com/en/directory?category=training", "http://biotech-spain.com/en/directory?category=foundatio", "http://biotech-spain.com/en/directory?category=foundation", "http://biotech-spain.com/en/directory?category=genomics", "http://biotech-spain.com/en/directory?category=hospitals", "http://biotech-spain.com/en/directory?category=infections", "http://biotech-spain.com/en/directory?category=engineering", "http://biotech-spain.com/en/directory?category=immunology", "http://biotech-spain.com/en/directory?category=healthcare-facilities-and", "http://biotech-spain.com/en/directory?category=scientific-t", "http://biotech-spain.com/en/directory?category=inter", "http://biotech-spain.com/en/directory?category=institutional-investor", "http://biotech-spain.com/en/directory?category=private-investor", "http://biotech-spain.com/en/directory?category=leasing", "http://biotech-spain.com/en/directory?category=environmental-cleanup-testing", "http://biotech-spain.com/en/directory?category=maintenance-cell-culture", "http://biotech-spain.com/en/directory?category=sales-marketing", "http://biotech-spain.com/en/directory?category=environment", "http://biotech-spain.com/en/directory?category=metabolomics", "http://biotech-spain.com/en/directory?category=microbiology", "http://biotech-spain.com/en/directory?category=nanotechnology", "http://biotech-spain.com/en/directory?category=neuroscience", "http://biotech-spain.com/en/directory?category=nutrition", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=oftalmology", "http://biotech-spain.com/en/directory?category=cost-optimization", "http://biotech-spain.com/en/directory?category=othe", "http://biotech-spain.com/en/directory?category=peptides", "http://biotech-spain.com/en/directory?category=science-tec", "http://biotech-spain.com/en/directory?category=probiotics", "http://biotech-spain.com/en/directory?category=blood-products", "http://biotech-spain.com/en/directory?category=disposable-medical-prod", "http://biotech-spain.com/en/directory?category=industrial-property-p", "http://biotech-spain.com/en/directory?category=proteins", "http://biotech-spain.com/en/directory?category=proteomics", "http://biotech-spain.com/en/directory?category=dna-tests", "http://biotech-spain.com/en/directory?category=diagnostic-tests", "http://biotech-spain.com/en/directory?category=scientific-publications", "http://biotech-spain.com/en/directory?category=chemistry", "http://biotech-spain.com/en/directory?category=human-resources", "http://biotech-spain.com/en/directory?category=research-network", "http://biotech-spain.com/en/directory?category=r", "http://biotech-spain.com/en/directory?category=animal-health", "http://biotech-spain.com/en/directory?category=women-s-health", "http://biotech-spain.com/en/directory?category=child-health", "http://biotech-spain.com/en/directory?category=mental-health", "http://biotech-spain.com/en/directory?category=senior-health", "http://biotech-spain.com/en/directory?category=healthy", "http://biotech-spain.com/en/directory?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/directory?category=screening", "http://biotech-spain.com/en/directory?category=food-safety", "http://biotech-spain.com/en/directory?category=cro-cmo-services", "http://biotech-spain.com/en/directory?category=research-services-and-supp", "http://biotech-spain.com/en/directory?category=legal-services", "http://biotech-spain.com/en/directory?category=auditory-system", "http://biotech-spain.com/en/directory?category=digestive-system", "http://biotech-spain.com/en/directory?category=kidney-and-geni", "http://biotech-spain.com/en/directory?category=locomotive-system", "http://biotech-spain.com/en/directory?category=metabolic-sy", "http://biotech-spain.com/en/directory?category=central-nervous-system", "http://biotech-spain.com/en/directory?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/directory?category=laser-optical-systems", "http://biotech-spain.com/en/directory?category=cellular-therapy", "http://biotech-spain.com/en/directory?category=gene-therapy", "http://biotech-spain.com/en/directory?category=tissue-therapy", "http://biotech-spain.com/en/directory?category=toxicology", "http://biotech-spain.com/en/directory?category=technology-transfer", "http://biotech-spain.com/en/directory?category=transplant", "http://biotech-spain.com/en/directory?category=universities", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=vaccines", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=venture-capital", "http://biotech-spain.com/en/directory?category=vitamins-and-nutri", "http://biotech-spain.com/en/directory?category=viral-vector"]}